JENNIFER DEFORGE: Open Payments
NPI 1356409742 · MERRITT ISLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 32 payments from 14 companies in 2025. Trend: 2023 $1,030 · 2024 $738 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $102 |
| ABBVIE INC. | 5 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Antares Pharma, Inc. | 1 | $33 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: JARDIANCE, LEQVIO, Kerendia, QULIPTA, Rybelsus, Ozempic, GEMTESA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
